Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
Left Ventricular Hypertrophy
About this trial
This is an interventional prevention trial for Left Ventricular Hypertrophy
Eligibility Criteria
Inclusion Criteria: Two blood pressure measurements greater than 140 mmHg systolic and greater than 90 mmHg diastolic on two separate vital sign checks obtained as part of routine ED care Exclusion Criteria: Subjects in extremis or lacking capacity to consent Active treatment of hypertension within the last year History of/known left ventricular hypertrophy Active cardiac disease under the care of a cardiologist within last year Suspicion for hypertensive emergency by treating ED physician Admission to the hospital
Sites / Locations
- Yale New Haven Hospital
Arms of the Study
Arm 1
Experimental
Feasibility: Disclosure, customized discharge and expedited referral instructions
Participants enrolled in the Aim 1 cohort with LVH on POCUS will receive the study intervention consisting of disclosure, counseling with set discharge instructions and expedited referral (communication to existing primary care physician OR referral to follow-up clinic if no existing primary care)